Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$990 4047
2024
Q4
$990 Hold
200
﹤0.01% 3566
2024
Q3
$1.05K Hold
200
﹤0.01% 3501
2024
Q2
$1.37K Hold
200
﹤0.01% 3404
2024
Q1
$2.06K Sell
200
-20,288
-99% -$150K ﹤0.01% 3361
2023
Q4
$170K Hold
20,488
﹤0.01% 1764
2023
Q3
$128K Buy
20,488
+20,288
+10,144% +$87.9K ﹤0.01% 1755
2023
Q2
$870 Hold
200
﹤0.01% 3265
2023
Q1
$340 Hold
200
﹤0.01% 3276
2022
Q4
$0 Buy
+200
New +$448 ﹤0.01% 4160

Other funds holding LFMD

NewEdge Advisors's LFMD Position: Q1 2025 in Review

NewEdge Advisors sold out of LifeMD (LFMD) in Q1 2025, closing a stake of 200 shares — an estimated $990 sold.

NewEdge Advisors first reported a position in LFMD in Q4 2022 and held it in 9 quarters. The position peaked at $170K in Q4 2023. 103 funds tracked by Wall St. Rank hold LFMD as of Q1 2025.

  • NewEdge Advisors reported no remaining LifeMD position as of Q1 2025 after selling out during the quarter.
  • NewEdge Advisors sold 200 LifeMD shares in Q1 2025, an estimated $990.
  • NewEdge Advisors first reported a position in LifeMD in Q4 2022 and held it in 9 quarters.
  • NewEdge Advisors's LifeMD position peaked at $170K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held LifeMD as of Q1 2025.

Based on NewEdge Advisors's 13F filing for Q1 2025, filed 15 May 2025.